SERTACONAZOLE 2%w/w IP

An antifungal agent against mycoses of the skin and mucosa, such as cutaneous, genital, candidiasis, and tinea pedis. (Alfonso Javier Carrillo-Muñoz, 2013) Offers rapid relief of symptoms and reduces the risk for relapse of tinea pedis. (Kircik, 2009) A broad-spectrum imidazole agent with antifungal, antibacterial, anti-inflammatory, and antipruritic properties. (Rosso, 2008) An effective topical option for the treatment of tinea pedis. (Ribotsky, 2009) Possesses both fungicidal and fungistatic properties to eradicate existing infections. (Ribotsky, 2009) Demonstrates a substantial improvement in signs and symptoms in individuals with interdigital tinea pedis. (Claudia Borelli, 2010) Superior to amorolfine 0.25%, both in terms of effectiveness and tolerability in tinea cruris/corporis patients. (Anirban Das, 2019) A therapeutic option in cutaneous dermatophytosis. (A Sharma, 2011) Offers better efficacy and tolerability in cutaneous dermatophytosis subjects as compared with the miconazole cream. (A Sharma, 2011) An excellent alternative therapeutic modality for treating seborrheic dermatitis. (Mohamad Goldust E. R., 2013) Shows a higher cure rate in vulvovaginal candidiasis patients than other topical azoles such as econazole and clotrimazole in a shorter period. (Alfonso Javier Carrillo-Muñoz, 2013) A better option than terbinafine and luliconazole in relieving signs and symptoms of dermatophytoses. (Hr Jerajani, 2013)